COVID-19 Prevention in Nursing Homes APE Opportunity, Emory

COVID-19 Prevention in Nursing Homes APE Opportunity, Emory

Opportunity Description

The COPING Study (COVID-19 Prevention in Nursing Homes) is an Emory University research study funded by the CDC that aims to examine COVID-19 serology among healthcare workers in nursing homes in Georgia. This APE opportunity is for Epi and BSHES masters students and primary data collection opportunity for Epi PhD students.

For this study, Dr. Scott Fridkin, the principal investigator, is looking for one or more students to assist with on-site data collection activities at participating nursing homes. All study staff, including any participating students, will be compliant with nursing homes’ requirements to be allowed on site.

See the flyer below for a more detailed description of the study and the position requirements.

How to Apply 


Log out of this account

Leave a Reply

Upcoming Events

  • Health Services Research Day May 6, 2025 at 8:00 am – 3:00 pm Conference / Symposium Event Type: Conference / SymposiumSpeaker: Keynote: Jennifer DeVoe, MD, DPhilContact Name: Melisa MezaContact Email: melisa.meza@emory.eduRoom Location: CNR PLAZA - Rollins AuditoriumLink: https://georgiactsa.org/research/cmdts/hsr.htmlThe Georgia CTSA and Emory Health Services Research Center are pleased to present the 11th annual Health Services Research Day - a symposium and networking opportunity where researchers learn about ongoing quality, effectiveness, and…
  • 2025 Charles C. Shepard Award Virtual Symposium May 7, 2025 at 12:00 pm – 1:00 pm Zoom emory.zoom.us… Online Location: Zoom https://emory.zoom.us/j/92336556594Speaker: Shepard finalistsContact Name: Flavia TravenContact Email: ftraven@emory.eduLink: https://emory.zoom.us/j/92336556594The Charles C. Shepard Award is given to the graduating master's students deemed by the faculty to have prepared the most scholarly research paper. Eight 2025 Charles C. Shepard Award finalists will present their work during the session.

Follow Us on Social Media: